The U.S. Congress is on track to fund a pivotal element of healthcare reform, a $50 million dollar down payment on the $500 million dollar Cures Acceleration Network (CAN) initiative. This is a critically important element of the landmark new law. It’s also an opportunity Congress should seize to refocus the National Institutes of Health … Continue reading “The Feds Need to Start Supporting Early-Stage Drug Development”
Author: Shawn Iadonato
Shawn Iadonato is chief scientific officer of Kineta